Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bausch Health Companies Inc (NY: BHC ) 6.430 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Jun 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Bausch Health Companies Inc < Previous 1 2 3 4 5 Next > Bausch Health Announces 2023 Annual Meeting of Shareholder Results May 17, 2023 Via ACCESSWIRE Bausch Health Observes Mental Health Awareness Month May 10, 2023 Via ACCESSWIRE Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023 May 08, 2023 Via ACCESSWIRE Bausch Health Announces First-Quarter 2023 Results May 04, 2023 Via ACCESSWIRE New Artificial Intelligence Tool Can Diagnose Colon Cancer May 03, 2023 A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and... Via PressReach Topics Artificial Intelligence Death Exposures Artificial Intelligence Death Product Safety Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel May 01, 2023 Via ACCESSWIRE Salix Partners with the Colorectal Cancer Alliance on Community Screening Program April 24, 2023 Via ACCESSWIRE Bausch Health to Announce First-Quarter 2023 Results on May 4 April 13, 2023 Via ACCESSWIRE New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider April 04, 2023 Via ACCESSWIRE Bausch Health Announces Changes to its Board of Directors March 01, 2023 Via ACCESSWIRE Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results February 23, 2023 Via ACCESSWIRE Salix Announces 2023 Gastrointestinal Health Scholars Program February 13, 2023 Via ACCESSWIRE Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23 February 01, 2023 Via ACCESSWIRE Bausch Health Announces Third-Quarter 2022 Results November 03, 2022 Via ACCESSWIRE Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference November 01, 2022 Via ACCESSWIRE Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge October 31, 2022 Via ACCESSWIRE Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case December 02, 2022 Via ACCESSWIRE Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider December 01, 2022 Via ACCESSWIRE Struggling Axsome Stock Could Bounce Back on Drug Trial Success November 30, 2022 Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. Via MarketBeat Exposures Product Safety Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents November 29, 2022 Via ACCESSWIRE Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference October 20, 2022 Via ACCESSWIRE Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022 November 04, 2022 Via ACCESSWIRE Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting October 24, 2022 Via ACCESSWIRE Bausch Health to Announce Third Quarter 2022 Results on Nov. 3 October 13, 2022 Via ACCESSWIRE Why These 3 Stocks Are Off to Hot September Starts September 13, 2022 Let’s look at what is behind the surprise rise in these three names—and whether they can continue to pace this month’s market rally. Via MarketBeat Topics Economy Exposures Economy Interest Rates Bausch Health Companies Inc. (NYSE:BHC) Shareholder Notice: Investigation over Potential Wrongdoing August 12, 2022 San Diego, CA -- (SBWIRE) -- 08/12/2022 -- An investigation as announced over potential breaches of fiduciary duties by certain directors at Bausch Health Companies Inc. Via SBWire NYSE:BHC Investor Notice: Investigation over Possible Securities Laws Violations by Bausch Health Companies Inc. May 18, 2022 San Diego, CA -- (SBWIRE) -- 05/18/2022 -- Bausch Health Companies Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire NYSE: BHC Shareholder Notice: Investigation over Potential Wrongdoing at Bausch Health Companies Inc. September 13, 2021 San Diego, CA -- (SBWIRE) -- 09/13/2021 -- An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing at Bausch Health Companies Inc. was... Via SBWire Topics Supply Chain Exposures COVID-19 Supply Chain Bausch Health Companies Inc. (NYSE:BHC) Investor Notice: Investigation over Possible Violations of Securities Laws August 16, 2021 San Diego, CA -- (SBWIRE) -- 08/16/2021 -- Bausch Health Companies Inc is under investigation over potential securities laws in connection with certain financial statements. Via SBWire Topics Supply Chain Exposures COVID-19 Supply Chain < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.